We are live on ! Find out more
NTUS

Natus Medical Inc
NTUS

Delisted

NTUS was delisted on the 20th of July, 2022.

Back to rankings

172 hedge funds and large institutions have $683M invested in Natus Medical Inc in 2020 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 66 increasing their positions, 56 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $3M | Put options by funds: $1.28M

33% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 21

18% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 56

4% more funds holding

Funds holding: 166 → 172 (+6)

7% less capital invested

Capital invested by funds: $735M → $683M (-$52.3M)

Holders
172
Holders Change
+6
Holders Change %
+3.61%
% of All Funds
3.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
66
Reduced
56
Closed
21
Calls
$3M
Puts
$1.28M
Net Calls
+$1.72M
Net Calls Change
+$4.85M

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$15.5M
2
Invesco
Invesco
Georgia
+$8.84M
3
Nordea Investment Management
Nordea Investment Management
Sweden
+$8.81M
4
BlackRock
BlackRock
New York
+$7.47M
5
Renaissance Technologies
Renaissance Technologies
New York
+$6.01M

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$27.3M
2
SAM
Silvercrest Asset Management
New York
-$26M
3
Victory Capital Management
Victory Capital Management
Texas
-$20.5M
4
CRM
Cramer Rosenthal McGlynn
Connecticut
-$8.52M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$3.86M
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
26
Arrowstreet Capital
Massachusetts
$7.47M +$348K +15,200 +5%
Charles Schwab
27
Charles Schwab
California
$6.83M -$1.26M -54,896 -15%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$6.41M +$3.12M +136,275 +86%
Principal Financial Group
29
Principal Financial Group
Iowa
$5.98M -$102K -4,470 -2%
Ameriprise
30
Ameriprise
Minnesota
$5.74M -$920K -40,181 -13%
MAM
31
Martingale Asset Management
Massachusetts
$4.99M +$1.04M +45,611 +25%
RCM
32
Rutabaga Capital Management
Massachusetts
$4.2M -$232K -10,116 -5%
Jacobs Levy Equity Management
33
Jacobs Levy Equity Management
New Jersey
$3.77M +$2.92M +127,607 +284%
Deutsche Bank
34
Deutsche Bank
Germany
$3.76M +$1.43M +62,396 +57%
CIM
35
Confluence Investment Management
Missouri
$3.33M -$58.6K -2,560 -2%
Assenagon Asset Management
36
Assenagon Asset Management
Luxembourg
$3.15M +$2M +87,367 +153%
BCC
37
Bridge City Capital
Oregon
$2.7M -$433K -18,895 -13%
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
$2.6M +$448K +19,580 +20%
Bank of America
39
Bank of America
North Carolina
$2.55M -$79K -3,452 -3%
AQR Capital Management
40
AQR Capital Management
Connecticut
$2.49M +$1.73M +75,732 +197%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$2.42M +$22.5K +983 +0.9%
Grantham, Mayo, Van Otterloo & Co (GMO)
42
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$2.41M +$1.98M +86,300 +355%
UBS Group
43
UBS Group
Switzerland
$2.28M +$1.64M +71,554 +217%
Legal & General Group
44
Legal & General Group
United Kingdom
$2.26M +$130K +5,670 +6%
Marshall Wace
45
Marshall Wace
United Kingdom
$2.19M +$1.44M +62,840 +168%
Morgan Stanley
46
Morgan Stanley
New York
$2.16M +$71.7K +3,132 +3%
MWNA
47
Marshall Wace North America
New York
$2.16M +$1.9M +82,858 +519%
Millennium Management
48
Millennium Management
New York
$2.11M +$2.22M +96,902 New
Bessemer Group
49
Bessemer Group
New Jersey
$2.08M +$22.9K +1,000 +1%
PCM
50
Polaris Capital Management
Massachusetts
$1.98M -$318K -13,900 -13%
1
2
3 4 5

NTUS Hedge Fund Activity: Q2 2020 in Review

172 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q2 2020, worth a combined $683M — down 7.1% from $735M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NTUS positions and 21 closed out — a net gain of 7 holders — while 66 added to existing stakes and 56 trimmed.

The largest buyer was Wells Fargo, adding an estimated $15.5M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $27.3M sold.

  • 172 institutional investors held Natus Medical Inc (NTUS) as of Q2 2020, up from 166 in Q1 2020.
  • Funds reported $683M of Natus Medical Inc stock for Q2 2020, down 7.1% quarter-over-quarter.
  • 28 funds opened new Natus Medical Inc positions in Q2 2020 and 21 closed out, a net change of +7 holders.
  • The largest Natus Medical Inc buyer in Q2 2020 was Wells Fargo, an estimated $15.5M added.
  • The largest Natus Medical Inc seller in Q2 2020 was Janus Henderson Group, an estimated $27.3M sold.

Based on aggregated 13F filings for Q2 2020.